IGF2BP1 and cancer: To prove the validity of these in silico evaluations, we validate three novel target mRNAs by demonstrating that IGF2BP1 promotes the expression of AURKA, HDLBP, and YWHAZ in cancer cells by impairing decay of the respective mRNAs.